Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) -21.6327.368.439.274.87

What is the latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS is -21.63 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar2024-21.63
Mar202327.36
Mar20228.43
Mar20219.27
Mar20204.87

How is Price to Cash Earnings (PCE) of GLENMARK PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 -21.63
Negative
Mar2023 27.36
224.56
Mar2022 8.43
-9.06
Mar2021 9.27
90.35
Mar2020 4.87 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹41,680.9 Cr -7.3% -4.8% 72.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,527.0 Cr -3.8% -3% 34.3% Stock Analytics
DIVIS LABORATORIES ₹156,037.0 Cr 0.9% 0.4% 53.5% Stock Analytics
CIPLA ₹116,854.0 Cr -2.8% -0.1% 9.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,746.0 Cr -2.4% 5.5% 17.5% Stock Analytics
ZYDUS LIFESCIENCES ₹99,093.9 Cr -2.4% -0.3% 42.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-7.3%

-4.8%

72.3%

SENSEX

-1.8%

-6.6%

7.1%


You may also like the below Video Courses